From: LATS2 is De-methylated and Overexpressed in Nasopharyngeal Carcinoma and Predicts Poor Prognosis
Parameters | Cases (n = 220) | LATS2 expression | Pvalue | |
---|---|---|---|---|
 |  | Low expression (n = 109) | High expression (n = 111) |  |
Age | Â | Â | Â | Â |
   < 46 | 104 | 56 | 48 | 0.227 |
   ≥46 | 116 | 53 | 63 |  |
Gender | Â | Â | Â | Â |
   Male | 166 | 77 | 89 | 0.100 |
   Female | 54 | 32 | 22 |  |
T stage | Â | Â | Â | Â |
   T1+T2 | 90 | 49 | 41 | 0.227 |
   T3+T4 | 130 | 60 | 70 |  |
N stage | Â | Â | Â | Â |
   N0 | 58 | 29 | 29 | 0.936 |
   N1+N2+N3 | 162 | 80 | 82 |  |
clinical stage | Â | Â | Â | Â |
   I + II | 54 | 29 | 25 | 0.482 |
   III + IV | 166 | 80 | 86 |  |
Histological type (WHO) | Â | Â | Â | Â |
   II | 58 | 28 | 30 | 0.882 |
   III | 162 | 81 | 81 |  |
Recurrence | Â | Â | Â | Â |
   Yes | 54 | 26 | 28 | 0.813 |
   No | 166 | 83 | 83 |  |
Metastasis | Â | Â | Â | Â |
   Yes | 29 | 14 | 15 | 0.883 |
   No | 191 | 95 | 96 |  |